SynthesisBMC cancer2022

Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature.

Laura Caquelin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.